Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis

Blaser, Cornelia; Klein, Matthias; Grandgirard, Denis; Wittwer, Matthias; Peltola, Heikki; Weigand, Michael; Koedel, Uwe; Leib, Stephen L. (2010). Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis. BMC infectious diseases, 10(84), p. 84. London: BioMed Central 10.1186/1471-2334-10-84

[img]
Preview
Text
1471-2334-10-84.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (282kB) | Preview

Bacterial meningitis in children causes high rates of mortality and morbidity. In a recent clinical trial, oral glycerol significantly reduced severe neurological sequelae in paediatric meningitis caused by Haemophilus influenzae type b, and a tendency towards a benefit of adjunctive glycerol was seen in pneumococcal meningitis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases > Research
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases

UniBE Contributor:

Grandgirard, Denis and Leib, Stephen

ISSN:

1471-2334

Publisher:

BioMed Central

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:12

Last Modified:

08 Jun 2016 10:21

Publisher DOI:

10.1186/1471-2334-10-84

PubMed ID:

20353584

Web of Science ID:

000277286300001

BORIS DOI:

10.7892/boris.2685

URI:

https://boris.unibe.ch/id/eprint/2685 (FactScience: 205551)

Actions (login required)

Edit item Edit item
Provide Feedback